Clinical and Immunological Effects of the Original and Biosimilar Rituximab in Patients With Rheumatoid Arthritis

Clinical pharmacology and therapy

doi 10.32756/0869-5490-2019-4-30-36

Full Text

Abstract

Available in

Date

Authors

Publisher

Pharmapress LLC

Related search

P133 Clinical and Immunological Effects of Tofacitinib Therapy in Rheumatoid Arthritis

2019English

Rituximab Therapy in Greek Patients With Rheumatoid Arthritis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials

Journal of Rheumatology
RheumatologyAllergyImmunology
2010English

Comparative Clinical Efficacy and Safety of the Proposed Biosimilar ABP 710 With Infliximab Reference Product in Patients With Rheumatoid Arthritis

Arthritis Research & Therapy
2020English

NK Cell Count as Predictor of Clinical Response in Patients With Rheumatoid Arthritis Treated With Rituximab

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

Assessment of Clinical and Immunological Efficacy and Safety of 23-Valent Pneumococcal Vaccine in Patients With Rheumatoid Arthritis

Pulmonologiya
PulmonaryRespiratory Medicine
2015English

Patients With Rheumatoid Arthritis in Clinical Care

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2004English

Safety of Rituximab in Rheumatoid Arthritis

Reumatismo
Rheumatology
2011English

Shared Immunological Targets in the Lungs and Joints of Patients With Rheumatoid Arthritis: Identification and Validation

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy